Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $16.75

Pediatrix Medical Group, Inc. (NYSE:MD) has been assigned an average recommendation of “Hold” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $17.08.

A number of research analysts recently issued reports on the company. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. UBS Group raised their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. Macquarie upped their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Thursday. Finally, Truist Financial lowered their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 11th.

Institutional Trading of Pediatrix Medical Group

Several hedge funds have recently made changes to their positions in MD. Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in shares of Pediatrix Medical Group during the first quarter worth about $159,000. Natixis Advisors LLC increased its position in Pediatrix Medical Group by 8.1% during the 1st quarter. Natixis Advisors LLC now owns 19,156 shares of the company’s stock worth $278,000 after purchasing an additional 1,435 shares during the period. XTX Topco Ltd raised its stake in shares of Pediatrix Medical Group by 246.5% during the 1st quarter. XTX Topco Ltd now owns 44,752 shares of the company’s stock worth $648,000 after buying an additional 31,835 shares in the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Pediatrix Medical Group by 82.7% in the 1st quarter. Mackenzie Financial Corp now owns 38,399 shares of the company’s stock valued at $556,000 after buying an additional 17,376 shares during the period. Finally, LPL Financial LLC boosted its stake in shares of Pediatrix Medical Group by 55.5% in the first quarter. LPL Financial LLC now owns 144,318 shares of the company’s stock valued at $2,091,000 after buying an additional 51,490 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 1.3 %

Shares of Pediatrix Medical Group stock opened at $14.63 on Monday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company has a fifty day simple moving average of $13.70 and a 200-day simple moving average of $14.03. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of -12.19, a PEG ratio of 1.74 and a beta of 1.26. Pediatrix Medical Group has a 12-month low of $6.62 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. During the same quarter in the prior year, the firm posted $0.20 earnings per share. Pediatrix Medical Group’s revenue for the quarter was down 7.4% on a year-over-year basis. On average, equities analysts forecast that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.